Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biogen Idec (NQ: BIIB )

257.68 -1.25 (-0.48%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Biogen Idec

< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Biogen Layoffs 2023: What to Know About the Latest BIIB Job Cuts
Biogen (BIIB) layoffs are on the way as the company seeks further profits with its upcoming Alzheimer's disease drug launch. 
Via InvestorPlace
Biogen Q2 Earnings Tops Expectations, Shift Resources To Higher Value Area(s), Layoff 1K Staff
Biogen Inc (NASDAQ: BIIB) posted Q2 FY23 sales of $2.46 billion, beating the con 
Via Benzinga
Biogen Inc. Tops Q2 Earnings And Revenue Estimates
Biogen Inc. came out with quarterly earnings of $4.02 per share. 
Via Talk Markets
Nasdaq Futures Rise Ahead Of Microsoft, Alphabet Earnings: Analyst Warns Of Volatility From Fed's Message 'Crafting'
Via Benzinga
All Eyes On Biogen's Alzheimer's Drug, A Big Potential Payday, Ahead Of Earnings
Analysts expect Biogen to report a a decline in both profits and sales in Q2. 
Via Investor's Business Daily
Better Big Biotech Buy: Vertex vs. Biogen
These companies have a track record of billion-dollar earnings. 
Via The Motley Fool
Biogen Earnings Preview
Via Benzinga
Biogen Unusual Options Activity
Via Benzinga
Goldman Sachs, Charles Schwab And This Healthcare Stock On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Biogen Inc. 
Via Benzinga
(BIIB) - Analyzing Biogen's Short Interest
Via Benzinga
Is Biogen Stock a Buy Now?
The biotech hasn't been the best investment recently. 
Via The Motley Fool
Should You Buy the Dip With Biogen Stock Right Now?
It's expected to grow, but things might not work out precisely as planned. 
Via The Motley Fool
These 2 Numbers Should Scare Every Biogen Shareholder
There are a couple of pieces of evidence that Biogen's long-term strategy isn't working. 
Via The Motley Fool
7 Stocks That AI Says Will Make You a Millionaire by 2025
These seven millionaire-maker stocks are changing hands at deeply undervalued levels. As their growth re-accelerates, so will your portfolio. 
Via InvestorPlace
P/E Ratio Insights for Biogen
Via Benzinga
Biogen Just Reached a Big Milestone. Why Isn't the Stock Rising?
Biogen shares are little changed year to date. 
Via The Motley Fool
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $4,900 Today
Via Benzinga
Why Isn't Biogen Stock Soaring After This Major FDA Approval?
Is the stock a good contrarian buy? 
Via The Motley Fool
Mixed Jobs Data; Fed Governors Want More Interest Rate Hikes; US, China Spat Rattles Semiconductor Sector: The Week In The Markets
Via Benzinga
Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts
The FDA approved a supplemental marketing application for Biogen Inc (NASDAQ: BIIB)-Eisai Co Ltd (OTC: ESALY) supporting the traditional approval of Leqembi (lecanemab-irmb), making it the first and... 
Via Benzinga
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
The FDA fully approved Biogen Inc.’s (NASDAQ: BIIB) Alzheimer’s treatment Leqembi on Thursday, becoming the first Alzheimer’s antibody treatment to reach full approval. 
Via Benzinga
What 29 Analyst Ratings Have To Say About Biogen
Via Benzinga
What's Going On With Biogen Stock Thursday
Biogen Inc (NASDAQ: BIIB) shares were flat in Thursday's after-hours session after falling marginally by 0.31% to $284.99 during  
Via Benzinga
Stock Market Rally Pulls Back As Yields Jump; Tesla, Meta In Focus: Weekly Review
Automakers rallied on sales while Meta's Threads had a big launch. 
Via Investor's Business Daily
FSLR Stock Alert: The $1 Billion Reason First Solar Is Up Today
First Solar (FSLR) stock is rising higher on Friday after the solar energy company announced a $1 billion revolving credit facility. 
Via InvestorPlace
Why Is Alibaba (BABA) Stock Up Today?
Alibaba (BABA) stock is on the rise Friday as investors react to a few pieces of news considering the Chinese e-commerce giant. 
Via InvestorPlace
BIIB Stock Alert: What to Know as FDA Approves Biogen’s Alzheimer’s Drug
Biogen (BIIB) stock is in the news Friday after the pharmaceutical company got approval from the FDA for its Alzheimer's drug. 
Via InvestorPlace
Stock Futures Dip As Traders Eye Friday Jobs Report: Analyst Says Q3 Returns Hinge More On This Catalyst Than Fed Move
Via Benzinga
Top 5 Trending Stocks: Prestige Wealth's IPO, Rivian's Lawsuit, Meta's New Platform, Tesla's Dip, And Biogen's FDA Approval
Via Benzinga
3 Biotech Stocks to Make Your ‘Get Rich’ Dreams Come True
These high return biotech stocks offer tremendous upside ahead and are likely to soar on the back of several growth drivers 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.